» Authors » Moonkyoo Kong

Moonkyoo Kong

Explore the profile of Moonkyoo Kong including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 51
Citations 355
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Noh J, Lee M, Lee Y, Bae M, Min S, Kong M, et al.
Mol Oncol . 2024 Sep; 19(2):540-557. PMID: 39297393
To enhance the efficacy of radiotherapy (RT) in human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC), we explored targeting ferroptosis, a regulated cell death process. We developed a...
2.
Cho Y, Park M, Choi M, Upadhyay T, Kang H, Oh J, et al.
Front Oncol . 2024 Sep; 14:1442737. PMID: 39267822
Background: Pancreatic cancer (PC), sometimes referred to as pancreatic ductal adenocarcinoma (PDAC), is a major cause of global mortality from cancer. Pancreatic cancer is a very aggressive and devastating kind...
3.
Kang J, Noh J, Lee M, Lee Y, Lee Y, Lee J, et al.
Ear Nose Throat J . 2024 Sep; :1455613241271686. PMID: 39258940
The size of T4 tumor could vary in oropharyngeal squamous cell carcinoma (OPSCC). Using the Surveillance, Epidemiology, and End Results (SEER) database, this study aimed to investigate the role of...
4.
Lee M, Woo S, Noh J, Min S, Kong M, Lee Y, et al.
Mol Cancer Ther . 2024 Jul; 23(9):1348-1359. PMID: 38959066
In this study, we developed and validated the clinical significance of senescence-associated secretory phenotype (SASP)-related gene signature and explored its association with radiation therapy (RT) in patients with head and...
5.
Lim Y, Kong M
Anticancer Res . 2023 Dec; 44(1):417-425. PMID: 38159981
Background/aim: There has been a growing trend toward a watch-and-wait strategy to avoid surgery. This study evaluated the prognostic outcomes of nonoperative management following chemoradiotherapy (CRT) in the very old...
6.
Woo S, Noh J, Ahn S, Lee M, Yu H, Min S, et al.
Anticancer Agents Med Chem . 2023 Nov; 24(1):50-57. PMID: 37921146
Background: Numerous studies have proven the efficacy and safety of natural products, and are widely used as attractive cancer treatments. The investigation of effective natural products for improving cancer treatment...
7.
Jeong Y, Eun Y, Lee S, Kang S, Yim S, Kim E, et al.
Mol Cancer . 2023 Sep; 22(1):147. PMID: 37674200
Gastric adenocarcinoma (GAC) is a lethal disease characterized by genomic and clinical heterogeneity. By integrating 8 previously established genomic signatures for GAC subtypes, we identified 6 clinically and molecularly distinct...
8.
Yoon Y, Choe M, Kong M, Chung W, Kim J, Lim Y
Front Oncol . 2022 Dec; 12:989190. PMID: 36479076
Introduction: Based on the immunologic effects of anti-cancer treatment and their therapeutic implications, we evaluated radiotherapy (RT)-induced dynamic alterations in programmed death-1 (PD-1)/PD ligand-1 (PD-L1) expression profiles. Methods: Local RT...
9.
Noh J, Woo S, Kong M, Lee M, Lee J, Lee Y, et al.
Mol Oncol . 2022 Oct; 17(1):134-149. PMID: 36271693
Although numerous studies have used systemic approaches to identify prognostic predictors in oral squamous cell carcinoma (OSCC), the effectiveness of these approaches has not been assessed clinically. Further, the mechanism...
10.
Kim S, Woo S, Noh J, Lee M, Lee Y, Lee J, et al.
BMC Cancer . 2022 Oct; 22(1):1077. PMID: 36261806
Background: Various cancer stem cell (CSC) biomarkers and the genes encoding them in head and neck squamous cell carcinoma (HNSCC) have been identified and evaluated. However, the validity of these...